Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
CME commentary: GLP-1 receptor agonists to prevent major cardiovascular adverse events (MACE) in type 2 diabetes (T2D), cardiovascular disease (CVD)
CCO downloadable PDF: benefits of continuous glucose monitoring; CGM tips for patients & providers from certified diabetes educator
Short video from CCO: Expert recommendations on identifying patients with diabetes most likely to benefit from continuous glucose monitoring
Expert slideset on when and how to leverage continuous glucose monitoring (CGM) data to inform management of patients with diabetes, from CCO
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.